乌洛托品生成甲醛的过程：pH值和浓度的影响以及抗菌效果。
Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect.
作者信息
Musher D M, Griffith D P
出版信息
Antimicrob Agents Chemother. 1974 Dec;6(6):708-11. doi: 10.1128/AAC.6.6.708.
Abstract
Using an in vitro system that simulates the dynamics of the urinary tract, we have shown that concentrations of formaldehyde >/= 25 mug/ml can be achieved in urine containing >/= 0.6 mg of methenamine per ml at pH </= 5.7 or >/= 1 mg/ml at pH </= 5.85. Exposure to this concentration of formaldehyde for 2 h produced a measurable antibacterial effect. These studies suggest that an effective bacteriostatic level of formaldehyde is likely to be achieved with currently used dosages of methenamine when the urine pH is less than 5.7 to 5.85.
摘要
通过使用一种模拟尿路动力学的体外系统，我们已经表明，在pH≤5.7时，每毫升含≥0.6毫克乌洛托品的尿液中可达到≥25微克/毫升的甲醛浓度；在pH≤5.85时，每毫升含≥1毫克乌洛托品的尿液中也可达到该浓度。暴露于这种浓度的甲醛2小时会产生可测量的抗菌效果。这些研究表明，当尿液pH小于5.7至5.85时，目前使用的乌洛托品剂量可能会达到有效的甲醛抑菌水平。
相似文献
1
Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect.乌洛托品生成甲醛的过程：pH值和浓度的影响以及抗菌效果。
Antimicrob Agents Chemother. 1974 Dec;6(6):708-11. doi: 10.1128/AAC.6.6.708.
2
The generation of formaldehyde from methenamine. Effect of urinary flow and residual volume.乌洛托品生成甲醛的过程。尿流和残余尿量的影响。
Invest Urol. 1976 Mar;13(5):380-2.
3
Effect of urine pH and ascorbic acid on the rate of conversion of methenamine to formaldehyde.尿液pH值和抗坏血酸对乌洛托品转化为甲醛速率的影响。
Biopharm Drug Dispos. 1993 Jan;14(1):61-9. doi: 10.1002/bdd.2510140106.
4
Formaldehyde generation from methenamine salts in spinal cord injury.脊髓损伤中乌洛托品盐产生甲醛的情况。
Arch Phys Med Rehabil. 1984 May;65(5):257-9.
5
The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate.接受扁桃酸乌洛托品治疗的截瘫患者尿液的抗菌活性。
Invest Urol. 1978 Sep;16(2):91-8.
6
Separation and quantitation of methenamine in urine by ion-pair extraction.
J Pharm Sci. 1986 Apr;75(4):416-20. doi: 10.1002/jps.2600750422.
7
8
Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.六亚甲基四胺和甲醛尿液药物水平的抗菌相关性。
Invest Urol. 1970 Jul;8(1):21-33.
9
Simultaneous determination of methenamine and formaldehyde in the urine of humans after methenamine administration.
Biopharm Drug Dispos. 1979 Jul-Sep;1(1):27-36. doi: 10.1002/bdd.2510010105.
10
Urinary excretion of methenamine and formaldehyde: evaluation of 10 methenamine products in humans.乌洛托品和甲醛的尿排泄：对10种乌洛托品产品在人体中的评估。
J Pharm Sci. 1981 Jun;70(6):596-9. doi: 10.1002/jps.2600700605.
引用本文的文献
1
Development of an LC-MS/MS Assay and Toxicokinetic Characterization of Hexamethylenetetramine in Rats.大鼠中六亚甲基四胺的液相色谱-串联质谱分析方法开发及毒代动力学特征研究
Toxics. 2023 Mar 31;11(4):337. doi: 10.3390/toxics11040337.
2
Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU).美替拉胺尿酸盐预防老年女性复发性尿路感染的随机、安慰剂对照试验方案（ImpresU）。
BMJ Open. 2022 Nov 1;12(11):e065217. doi: 10.1136/bmjopen-2022-065217.
3
The Impact of Methenamine Hippurate Treatment on Urothelial Integrity and Bladder Inflammation in Aged Female Mice and Women With Urinary Tract Infections.三聚氰胺尿酸盐治疗对老年雌性小鼠和尿路感染女性患者尿路上皮完整性和膀胱炎症的影响。
Female Pelvic Med Reconstr Surg. 2022 Jun 1;28(6):e205-e210. doi: 10.1097/SPV.0000000000001185. Epub 2022 Apr 28.
4
3DG Functionalized Magnetic Solid Phase Extraction Materials for the Efficient Enrichment of Hexamethylenetetramine in Vermicelli.3DG 功能化磁性固相萃取材料用于粉丝中六亚甲基四胺的高效富集。
Molecules. 2022 Feb 25;27(5):1548. doi: 10.3390/molecules27051548.
5
Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis.患有临床型和亚临床型乳腺炎的奶牛瘤胃微生物群结构及代谢物活性
J Anim Sci Biotechnol. 2021 Feb 8;12(1):36. doi: 10.1186/s40104-020-00543-1.
6
Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment Outcomes.使用含乌洛托品和亚甲蓝的尿路抗菌剂治疗复发性尿路感染症状：病因分析与治疗结果
Res Rep Urol. 2020 Dec 15;12:639-649. doi: 10.2147/RRU.S279060. eCollection 2020.
7
An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.从传染病学和药代动力学角度看口服抗生素治疗多重耐药革兰氏阴性尿路病原体所致单纯性尿路感染：尿抗生素浓度和尿pH值的重要性
Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):521-6. doi: 10.1007/s10096-016-2577-0. Epub 2016 Feb 9.
8
The large scale antibacterial, antifungal and anti-phage efficiency of Petamcin-A: new multicomponent preparation for skin diseases treatment.培他霉素A的大规模抗菌、抗真菌和抗噬菌体效果：用于治疗皮肤病的新型多组分制剂
Ann Clin Microbiol Antimicrob. 2015 May 18;14:28. doi: 10.1186/s12941-015-0087-z.
9
Physiological responses of Pseudomonas putida to formaldehyde during detoxification.恶臭假单胞菌在甲醛解毒过程中的生理响应。
Microb Biotechnol. 2008 Mar;1(2):158-69. doi: 10.1111/j.1751-7915.2007.00014.x.
10
An in vitro model for assessing optimum antibiotic dosage in urinary tract infection.一种用于评估尿路感染最佳抗生素剂量的体外模型。
Infection. 1980;Suppl 1:35-8. doi: 10.1007/BF01644933.
本文引用的文献
1
Activity products in stone-forming and non-stone-forming urine.形成结石和不形成结石的尿液中的活性产物。
Clin Sci. 1968 Jun;34(3):579-94.
2
The Riker method for determining formaldehyde in the presence of methenamine.
Invest Urol. 1971 Sep;9(2):124-9.
3
Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.六亚甲基四胺和甲醛尿液药物水平的抗菌相关性。
Invest Urol. 1970 Jul;8(1):21-33.
4
Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid.乙酰氧肟酸增强乌洛托品的抗菌作用。
Antimicrob Agents Chemother. 1974 Feb;5(2):101-5. doi: 10.1128/AAC.5.2.101.
Zotero 插件